Does INTERFERON BETA-1A Cause Dyslipidaemia? 9 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 9 reports of Dyslipidaemia have been filed in association with INTERFERON BETA-1A (Avonex). This represents 0.0% of all adverse event reports for INTERFERON BETA-1A.
9
Reports of Dyslipidaemia with INTERFERON BETA-1A
0.0%
of all INTERFERON BETA-1A reports
1
Deaths
3
Hospitalizations
How Dangerous Is Dyslipidaemia From INTERFERON BETA-1A?
Of the 9 reports, 1 (11.1%) resulted in death, 3 (33.3%) required hospitalization.
Is Dyslipidaemia Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for INTERFERON BETA-1A. However, 9 reports have been filed with the FAERS database.
What Other Side Effects Does INTERFERON BETA-1A Cause?
Multiple sclerosis relapse (5,931)
Influenza like illness (4,475)
Memory impairment (3,468)
Multiple sclerosis (3,412)
Fatigue (3,164)
Fall (3,128)
Gait disturbance (3,031)
Death (2,766)
Pain (2,692)
Headache (2,533)
What Other Drugs Cause Dyslipidaemia?
OLANZAPINE (230)
ROSUVASTATIN (206)
ARIPIPRAZOLE (185)
METHOTREXATE (175)
QUETIAPINE (161)
ATORVASTATIN (155)
RISPERIDONE (154)
METFORMIN (151)
TACROLIMUS (149)
ZIPRASIDONE (149)
Which INTERFERON BETA-1A Alternatives Have Lower Dyslipidaemia Risk?
INTERFERON BETA-1A vs INTERFERON BETA-1B
INTERFERON BETA-1A vs INTERFERON GAMMA
INTERFERON BETA-1A vs INTERFERON GAMMA-1B
INTERFERON BETA-1A vs INVEGA
INTERFERON BETA-1A vs INVEGA SUSTENNA